Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to crown any winners in the race for the next generation of anti-obesity treatments.Read more...

Quartz

United States

The race for the next Ozempic is on

Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and other medications like it have a host of other potential health benefits beyond obesity, but could also bring increased risk of other conditions.

Ad Fontes Media

All Sides

Media Bias/Fact Check

CBC News

Government of Canada

Canada

Drugs like Ozempic could also curb addictions — but they might boost other health risks, study suggests

Weight-loss drugs such as Ozempic can help people to lose more than a fifth of their body weight and have been linked to a range of other health benefits, but also some concerns.

Sydney Morning Herald

Nine Entertainment Co.

Sydney

New South Wales

Australia

Sweeping study finds 42 health conditions Ozempic can improve – and 19 it makes worse

Two new studies indicate that people who take medications containing the substance Semaglutide – which is found in the popular diabetes medication Ozempic, among other things – are at an increased risk of developing the eye disease Naion. The European Medicines Agency's Safety Committee PRAC has therefore begun a review of medications such as Ozempic, the Swedish Medicines Agency writes...

Två nya studier vittnar om att personer som tar läkemedel med substansen Semaglutid – som bland annat finns i den populära diabetesmedicinen Ozempic – löper en ökad risk för att utveckla ögonsjukdomen Naion. Europeiska läkemedelsmyndighetens säkerhetskommitté PRAC har därför påbörjat en granskning av läkemedel som Ozempic, skriver Läkemedelsverk...

Ozempic granskas efter studier

Svenska Dagbladet

Schibsted

Stockholm

Stockholm County

Sweden

Ozempic under review after studies

Miracle drugs to treat diabetes and obesity, glucagon-like peptide-like agonists type 1 (GLP-1RA), may still have other health benefits unknown, says a study published in 'Nature Medicine', but also negative.The study, conducted by scientists at the University of Washington at St. Louis, USA, in more than 2.4 million people.

Los medicamentos milagrosos para tratar la diabetes y la obesidad, los agonistas del receptor del péptido similar al glucagón tipo 1 (GLP-1RA), podría tener otras beneficios para la salud desconocidos todavía, asegura un estudio que se publica en ' Nature Medicine ', pero también negativos.El estudio, realizado por científicos de la Universidad de Washington en St. Louis (EEUU.), en más de 2,4 millones de personas., revela que, aunque los medica…

Pros y contras de los milagrosos fármacos para la obesidad

Grupo Vocento

Spain

Pros and cons of miraculous drugs for obesity

The active ingredients in so-called “weight loss injections” appear to help with more health problems than just type 2 diabetes and obesity. But they also have side effects, a study shows.

Die Wirkstoffe der sogenannten „Abnehmspritzen“ scheinen bei mehr gesundheitlichen Problemen zu helfen als Diabetes Typ 2 und Fettleibigkeit. Doch sie haben auch Nebenwirkungen, zeigt eine Studie.

„Abnehmspritze“: Studie findet Nutzen und Risiken

Frankfurter Allgemeine

Frankfurt

Hesse

Germany

“Weight loss injection”: Study finds benefits and risks

Now, according to American research, it appears that slimming injections can solve dozens of health problems such as cardiovascular diseases and dementia. But beware: they can also cause other ailments.

Nu blijkt volgens Amerikaans onderzoek dat afslankinjecties tientallen gezondheidsproblemen kunnen oplossen zoals hart- en vaatziekten en dementie. Maar let op: ze kunnen ook juist voor andere kwalen zorgen.

’Afslankinjecties lossen tientallen gezondheidsproblemen op, maar zorgen ook voor extra kwalen’

De Telegraaf

Mediahuis

Amsterdam

Government of Amsterdam

North Holland

Netherlands

'Weight loss injections solve dozens of health problems, but also cause additional ailments'

After changing the obesity situation, will GLP-1 drugs do even better?

Après avoir changé la donne face à l'obésité, les médicaments GLP-1 feront-ils encore mieux ?

Ozempic, Mounjaro... Des médicaments prometteurs bien au-delà de l'obésité

TVA Nouvelles

Montreal

Quebec

Ozempic, Mounjaro... Promising drugs well beyond obesity

While Ozempic has been praised for its ability to induce weight loss and treat a range of health conditions, it could also lead to an increased risk of arthritis, gastrointestinal disorders and other issues, according to new research.The US study published in the Nature Medicine journal highlighted that drugs such as Ozempic, called glucagon-like peptide-1 (GLP-1) receptor agonists, can treat more than just obesity but have potential positive an…

9News

Ozempic increases risk of arthritis and stomach issues, study finds

New weight loss drugs like Ozempic appear to offer many more health benefits than previously known. Major American research shows...

Nieuwe afslankmedicijnen als Ozempic blijken veel meer gezondheidsvoordelen op te leveren dan tot nu toe bekend was. Groot Amerikaans onderzoek wijst...

Afslankmedicijnen blijken verrassend effectief tegen 42 aandoeningen: van psychose tot leverfalen

Volkskrant

DPG Media

Diet drugs prove surprisingly effective against 42 conditions: from psychosis to liver failure

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing them as miracle drugs.

The race for the next Ozempic is on

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics